Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01636011 · ClinicalTrials.gov registry record · NA

Effect of Osteopathic Manipulative Medicine (OMM) on Pulmonary Function and Speech in Parkinson's Disease

A NA study, sponsored by New York Institute of Technology.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT01636011: Completed NA study, sponsored by New York Institute of Technology.

NCT01636011 is a NA study that has completed, run by New York Institute of Technology. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01636011, a NA study, has completed, sponsored by New York Institute of Technology.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the effect of selected Osteopathic Manipulative Medicine (OMM) techniques on the respiratory system of people with Parkinson's Disease (PD) in comparison to light touch. Effectiveness will be measured through pulmonary function tests, chest wall expansion, and voice analysis. Selected subjects will be randomly assigned to one of the two groups: OMM treatment group or light touch group. Although OMM treatment has been used on PD patients, a randomized controlled study has not been done to establish its effect on PD respiratory function. The authors believe that this study will show OMM's effectiveness.

Interventions

  • OTHER Osteopathic Manipulative Medicine Treatment
  • OTHER Light Touch sham

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2013-02
Est. Completion 2017-05
Phase NA
New York Institute of Technology

49 total trials

What the finished NCT01636011 record still lists

NCT01636011 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Osteopathic Manipulative Medicine Treatment is the first listed.

NCT01636011 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01636011 about?

NCT01636011 is a clinical study titled "Effect of Osteopathic Manipulative Medicine (OMM) on Pulmonary Function and Speech in Parkinson's Disease". The purpose of this study is to investigate the effect of selected Osteopathic Manipulative Medicine (OMM) techniques on the respiratory system of people with Parkinson's Disease (PD) in comparison to light touch. Effectiveness will be measured through pulmonary function tests, chest wall expansion,...

What is the current status of trial NCT01636011?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-02. Estimated completion is 2017-05.

What interventions are being tested in trial NCT01636011?

The interventions under investigation include: Osteopathic Manipulative Medicine Treatment (OTHER), Light Touch sham (OTHER).

Who is sponsoring clinical trial NCT01636011?

This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01636011's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01636011, the US trial registry maintained by the National Library of Medicine. NCT01636011 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.